Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
about
Targeting BMP signalling in cardiovascular disease and anaemiaAge-Related Macular Degeneration and Intracrine Biology: An HypothesisDMH1 increases glucose metabolism through activating Akt in L6 rat skeletal muscle cellsMurine pressure overload models: a 30-MHz look brings a whole new "sound" into data interpretation.Aliskiren-attenuated myocardium apoptosis via regulation of autophagy and connexin-43 in aged spontaneously hypertensive rats.Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.(4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl] quinoline) is a novel inhibitor of autophagyThe association between BMP4 gene polymorphism and its serum level with the incidence of LVH in hypertensive patientsAttenuation of Cerebral Ischemic Injury in Smad1 Deficient Mice.Mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone induces vasorelaxation without involving KATP channel activation in smooth muscle cells of arteriesThe Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling.Oestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy.Resveratrol Ameliorates Cardiac Hypertrophy by Down-regulation of miR-155 Through Activation of Breast Cancer Type 1 Susceptibility Protein.BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.Inhibitory Effect of Bone Morphogenetic Protein 4 in Retinal Pigment Epithelial-Mesenchymal TransitionHydrogen Sulfide Improves Endothelial Dysfunction via Downregulating BMP4/COX-2 Pathway in Rats with HypertensionNovel transcriptome assembly and comparative toxicity pathway analysis in mahi-mahi (Coryphaena hippurus) embryos and larvae exposed to Deepwater Horizon oilAldosterone mediates cardiac fibrosis in the setting of hypertension.Bone morphogenetic protein-4: a novel therapeutic target for pathological cardiac hypertrophy/heart failure.Regulators and effectors of bone morphogenetic protein signalling in the cardiovascular system.LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9c2 embryonic rat cardiomyocytes.Bone morphogenetic protein-4 induces upregulation of Cav3.1 Ca²⁺ channels in HL-1 atrial myocytes.Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis.Boldine improves endothelial function in diabetic db/db mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascadeAcetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling.Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population.Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice.Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction.Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications.Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries.Bone morphogenetic protein-2 antagonizes bone morphogenetic protein-4 induced cardiomyocyte hypertrophy and apoptosis.Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.The detrimental effects of glucocorticoids exposure during pregnancy on offspring's cardiac functions mediated by hypermethylation of bone morphogenetic protein-4
P2860
Q26783734-3E5F366E-ABC1-478B-87F4-B20B861173DFQ28072590-A5803FCD-BD3A-4A95-B1D9-1DC38B129246Q28543162-F705107C-25D2-4481-9CF0-6FE8A367EC3BQ30838476-3BDF8853-4580-4FA3-98BF-8D77AD49B3F3Q34011428-CCD4B829-AB7D-4D42-9F8F-3E85FCB9AA49Q34025148-42A84D84-84FC-4AA7-8766-EF641DF2A8B7Q34954139-DF29561F-F289-40A9-9534-EBB4C9B36630Q35071523-509CBBE1-A6F8-45E0-AC6C-917B90654854Q35758451-99340281-07B0-4395-A089-021F4795F108Q36106217-0869CF2F-2769-4BDC-8143-96A094C9128AQ36170775-FA9032C3-BB3C-4B92-BC1A-8D68C9AAE591Q36342177-6F8D4F25-AFD5-4EE8-9739-4842506C4232Q36831838-817DC9C9-E86F-42D5-8A77-391719380ECDQ36902288-71208F28-D1BC-49A6-8BD5-58049467CA66Q37032218-DD5735AE-3405-4498-B62A-579CABED31B2Q37127457-70DA2E62-B5D1-4FB7-A0CD-27EA6EB3EDB9Q37227950-23C6BC11-BA00-4323-BA5D-849B53F086DEQ37232393-F9154887-7DE2-4C42-8089-A122085E6371Q37704595-D47FC6AF-95DB-4A21-98FF-A17BB21004BDQ38107897-1DF5F7AA-BE51-4DA0-A425-D912251C1381Q38204900-05A276F7-C644-46E8-8D7D-06AC5E404998Q38465654-EBADA9FE-7665-46F4-9706-80A9ACD8014CQ38718930-B9379B53-D140-4145-B5C9-EC0825ECC525Q39025756-25F7AB34-2D91-4B2B-A325-F0B7ED4EB85DQ40163840-0D3A986C-ECBE-40F3-A2C4-A9CAC8FB9919Q41010363-A93F7080-EB9F-4E55-BF63-6773D99A8025Q41824130-7E670C2E-B992-439F-BB5B-8BB2AD0B8325Q46260161-CFEA8E57-0694-4EDB-A815-06ED600128ECQ47615847-98F7B280-7885-4FD9-AEA4-212D97C57999Q47671193-DB12176B-484E-4E80-97E5-6377ABC1411FQ47676686-DE033A16-3C9E-49AE-915F-B0314355CAD9Q48189809-73787C34-6DBD-4D2E-B3FF-B16687D97811Q51035065-331E4C9B-AA47-4CC3-8E26-A370AEA4D164Q52359177-C7A7D26A-84C0-4DC2-8F81-20028A45A455Q52684683-920A2F8C-1197-4A90-A8B9-BED6AC95D38AQ54124127-2452E122-8C9B-4412-8571-737882EA0DC3Q54367129-8053AD23-DECA-4A55-9606-6584953EE018Q55294487-4CA866CB-1CC6-496F-8B20-8840038CEABDQ58799618-BE676342-D64D-401A-A2B3-79463BFB819B
P2860
Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Bone morphogenetic protein-4 m ...... hological cardiac hypertrophy.
@en
Bone morphogenetic protein-4 m ...... hological cardiac hypertrophy.
@nl
type
label
Bone morphogenetic protein-4 m ...... hological cardiac hypertrophy.
@en
Bone morphogenetic protein-4 m ...... hological cardiac hypertrophy.
@nl
prefLabel
Bone morphogenetic protein-4 m ...... hological cardiac hypertrophy.
@en
Bone morphogenetic protein-4 m ...... hological cardiac hypertrophy.
@nl
P2093
P1433
P1476
Bone morphogenetic protein-4 m ...... hological cardiac hypertrophy.
@en
P2093
Bao-Feng Yang
Chang Chen
Cheng-Bo Li
De-Li Dong
Hui-Bin Liu
Jiu-Xin Zhu
Wen-Ting Guo
P304
P356
10.1161/HYPERTENSIONAHA.111.00562
P407
P577
2012-12-17T00:00:00Z